Announcement
Thank you for attending THSNA 2026. The virtual meeting is now closed.
Thank you for attending THSNA 2026. The virtual meeting is now closed.
Poster Session > Session
Virtual Posters
Presentations
A1. ANTICOAGULATION CLINICS | |||||
|
ADEQUACY OF STANDARD THERAPEUTIC LOW–MOLECULAR-WEIGHT HEPARIN DOSING IN PREGNANT WOMEN WITH PROSTHETIC HEART VALVES: AN ANTI-FACTOR XA–BASED EVALUATION (THSNA TRAVEL AWARDEE) Tushar Sehgal1, K.Aparna Sharma2, Ambuj Roy3. 1Department of Laboratory Medicine, Delhi, India 2Department of Obstetrics and Gynaecology, Delhi, India 3Department of Cardiology, Delhi, India |
|||||
A6. DISORDERS OF COAGULATION OR FIBRINOLYSIS | |||||
|
(2) OPTIMIZING ANTICOAGULANT STRATEGIES IN PREGNANCY-ASSOCIATED HIT AND ACUTE STROKE IN A REAL-WORLD COMMUNITY SETTING Pedrom Farid1,2,3, Marco A Herrera Quijano1,2,3, Omar Samarraie2, Andrea Cervi1,2,3. 1Schulich School of Medicine and Dentistry, Western University, London, ON, Canada 2University of Windsor, Windsor, ON, Canada 3Windsor Regional Hospital, Windsor, ON, Canada |
||||
|
(3) TRENDS IN AGE-ADJUSTED MORTALITY RATES FOR DISSEMINATED INTRAVASCULAR COAGULATION IN SOLID AND HEMATOLOGIC CANCER PATIENTS: A 22-YEAR ANALYSIS OF UNITED STATES MORTALITY DATA BY SEX, RACE, AND GEOGRAPHIC REGION, 1999-2020. Jiss Joy1, Rahul Anand1, Joan D. Beckman2. 1Department of Internal Medicine, The Guthrie Clinic, Robert Packer Hospital, Sayre, PA, USA 2Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA |
||||
A7. PATHOPHYSIOLOGY OF THROMBOSIS | |||||
|
(4) COULD ELEVATED HOMOCYSTEINE BE A RISK FACTOR FOR CEREBRAL VENOUS THROMBOSIS? Nawris Alhassan1, Jagdish Lal2, Susmin Karki3. 1Hope Clinic, Midvale, UT, USA 2Burnaby Chronic Pain & Rehabilitation Clinic, Burnaby, BC, Canada 3Institute of Medicine, Tribhuvan University, Maharajgunj, Nepal |
||||
|
(6) VENOUS THROMBOEMBOLISM IN INTERNAL MEDICINE INPATIENTS: A ONE-YEAR PILOT STUDY OF PREVALENCE, PATIENT CHARACTERISTICS, AND SURVIVAL OUTCOMES FROM TURKEY. Bulent Kantarcioglu1,3, Sultan Gozde Temiz2, Ayse Nilgun Kul1, Jawed Fareed3, Gulbuz Sezgin2. 1University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey 2University of Health Sciences, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Department of Internal Medicine, Istanbul, Turkey 3Loyola University Chicago, Department of Pathology & Laboratory Medicine, Cardiovascular Research Institute, Health Science Division, Maywood, IL, USA |
||||
|
(7) DIAGNOSTIC PERFORMANCE OF THE KHORANA, ONKOTEV, AND PROTECHT SCORES FOR PREDICTING VENOUS THROMBOEMBOLISM IN OVARIAN CANCER Emilie Matheson1, Wesley Chorney1, Rahul Singh1, Susan O'Shea1,2. 1University College Cork, Cork, Ireland 2Bons Secours Hospital, Cork, Ireland |
||||
A8. ANTITHROMBOTIC THERAPY | |||||
|
(8) INTERVENTIONAL THROMBOLYSIS VS ANTICOAGULATION ALONE FOR MYELOPROLIFERATIVE NEOPLASM-ASSOCIATED ACUTE VENOUS THROMBOEMBOLISM: A REAL-WORLD PROPENSITY-MATCHED ANALYSIS Hassaan J. Abbasi1, Devi Preetham R. Veeramagri1, Yashar Haghighi1, Patrick J. Willard2, Christopher W. Bailey3. 1Virginia Commonwealth University School of Medicine, Richmond, VA, USA 2Department of Hematology-Oncology, VCU Health, Richmond, VA, USA 3Division of Vascular Interventional Radiology, VCU Health, Richmond, VA, USA |
||||
|
(9) TO CLOT OR NOT - RISK OF HOSPITAL-ACQUIRED VENOUS THROMBOEMBOLISM IN PATIENTS PRESCRIBED ASPIRIN AFTER TOTAL HIP ARTHROPLASTY/TOTAL KNEE ARTHROPLASTY Amy N. Cruz1, Josh Roberts1, Jeremiah Duby1, James Chhen1, Michelle Krichevsky2, Tiffany Pon1,2. 1University of California Davis, Sacramento, CA, USA 2University of California San Francisco, San Francisco, CA, USA |
||||
|
(10) NOVEL THERAPEUTIC LIMITS CHRONIC INFLAMMATION IN ANIMAL MODELS OF CHRONIC INFLAMMATION. P Iversen1, P Kempaiah2, G Dorn2, E Campbell2, Z Kakabadze3, E Ramacciotti4, J Fareed2. 1.Oregon State University, Corvallis, OR, USA 2Loyola University Medical Center, Maywood, IL, USA 3Tbilisi State Medical University, Tbilisi, Georgia 4Science Valley Research Institute, Sao Paulo, Brazil |
||||
|
(11) PARADOXICAL APIXABAN ANTI-XA LEVELS AFTER ANDEXANET ALFA: A CASE REPORT ON UNRELIABLE LABORATORY MONITORING AND EARLY THROMBOTIC RISK Sean Twardy1, Farzeen Syed2, Shelley Kalsi2. 1Uniformed Services University of the Health Sciences, Bethesda, MD, USA 2National Institutes of Health, Bethesda, MD, USA |
||||
A9. INFORMATIONAL ABSTRACT (POSTER ONLY) | |||||
|
(12) IMPLEMENTING A STRUCTURED, MULTIDISCIPLINARY HOME INFUSION EDUCATION PROGRAM FOR PEDIATRIC BLEEDING DISORDERS Julie Bascones, Branden Beria, Aimee Foord. Cure 4 the Kids Foundation, Las Vegas, NV, USA |
||||
|
(14) IS PSEUDOTHROMBOCYTOPENIA ONLY A LABORATORY IN VITRO PHENOMENON? Marika Pikta1,2, Laura Johanna Mettis3,4, Maria Keernik5, Kristi Lepik6, Kadri Saks6. 1Department of Laboratory Medicine, North Estonia Medical Centre, Tallinn, Estonia 2Department of Health Technologies, Tallinn University of Technology, Tallinn, Estonia 3Hematology Department, North Estonia Medical Centre, Tallinn, Estonia 4University of Helsinki, Helsinki, Finland 5Department of Laboratory Genetics, University of Tartu, Tartu, Estonia 6Haematology Department, Tallinn Children`s Hospital, Tallinn, Estonia |
||||
|
(15) DIAGNOSTIC LIMITATION OF MIXING STUDIES IN COAGULATION ASSAY Maryam Pourabdollah. University of Ottawa, OTTAWA, ON, Canada |
||||
A4. DISORDERS OF PLATELET NUMBER OR FUNCTION | |||||
|
(402) DRUG-INDUCED THROMBOCYTOPENIA FROM PROTON PUMP INHIBITORS AND H₂ BLOCKERS: A SYSTEMATIC REVIEW AND COMPARATIVE ANALYSIS OF PUBLISHED CASE REPORTS Swapnil Surpur, Himani Mongia, Sameer Bhimani, Mohamed Ahmed, Teodor Lazic, James Cortese. The Wright Center for GME, Scranton, PA, USA |
||||
A9. INFORMATIONAL ABSTRACT (POSTER ONLY) | |||||
|
(418) AN UNUSUAL PRESENTATION OF MULTIPLE MYELOMA WITH SPONTANEOUS SUBARACHNOID HEMORRHAGE FROM SKULL BASE INVOLVEMENT AND THROMBOCYTOPENIA: CASE REPORT AND LITERATURE REVIEW Swapnil Surpur, Sameer Bhimani, Ifunanya Ekechukwu, Tushar Abhinav, Aadhyaa Shenoy, James Cortese. The Wright Center for GME, Scranton, PA, USA |
||||
A6. DISORDERS OF COAGULATION OR FIBRINOLYSIS | |||||
|
(607) COMPARATIVE ANALYSIS OF CANCER-INDUCED VENOUS THROMBOEMBOLISM PREDICATORS AND RISK ASSESSMENT MODELS: A SYSTEMATIC REVIEW Tarek A. Issa1, Noor A. Haykal1, Yasmin M. Elsayed1, Islam A. Eljilany2, Hazem F. Elewa1. 1College of Pharmacy, QU Health, Qatar University, Doha, Qatar 2H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA |
||||